NCT01817270View on ClinicalTrials.gov

Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Chickenpox
Interventions
BIOLOGICAL

Live Attenuated Varicella Vaccine

Trial Locations (1)

Unknown

Xinxing Center for Disease Control and Prevention, Yunfu

All Listed Sponsors
collaborator

Guangdong Provincial Institute of Biological Products And Materia Medica

OTHER

lead

Changchun Keygen Biological Products Co., Ltd.

OTHER

NCT01817270 - Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine | Biotech Hunter | Biotech Hunter